Q4 2023 ImpediMed Ltd Cashflow Reports Call Transcript
Thank you for standing by. And welcome to the ImpediMed Limited quarterly results conference call. (Operator Instructions)
I would now like to hand the conference over to Mr. Rick Valencia, Managing Director and CEO. Please go ahead.
Thank you, Zach. Good morning, everyone, and thank you for joining us on our quarterly 4C call today. We had a strong close to our fiscal year 2023. As we suggested would happen after our inclusion in the NCCN Survivorship Guidelines, we're gaining significant momentum with private payers with our first top 5 national payer publishing medical policy in less than 5 months from our inclusion in the guidelines. In addition, our pipeline has never been richer and the level of customer engagement has markedly improved. For example, we closed on an 8 SOZO system deal in Michigan last quarter that was upsized at the last minute because of the significantly improved ROI we delivered after getting the critical mass in that market. That's just one example of the type of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |